- Home
- FMY vs EDAP Comparison
FMY vs EDAP Comparison
Compare FMY & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- EDAP
- Stock Information
- Founded
- FMY 2005
- EDAP 1979
- Country
- FMY United States
- EDAP France
- Employees
- FMY N/A
- EDAP N/A
- Industry
- FMY Finance/Investors Services
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FMY Finance
- EDAP Health Care
- Exchange
- FMY Nasdaq
- EDAP Nasdaq
- Market Cap
- FMY 50.6M
- EDAP 53.8M
- IPO Year
- FMY N/A
- EDAP 1997
- Fundamental
- Price
- FMY $12.02
- EDAP $1.78
- Analyst Decision
- FMY
- EDAP Buy
- Analyst Count
- FMY 0
- EDAP 3
- Target Price
- FMY N/A
- EDAP $8.50
- AVG Volume (30 Days)
- FMY 10.1K
- EDAP 53.4K
- Earning Date
- FMY 01-01-0001
- EDAP 05-15-2025
- Dividend Yield
- FMY 6.98%
- EDAP N/A
- EPS Growth
- FMY N/A
- EDAP N/A
- EPS
- FMY N/A
- EDAP N/A
- Revenue
- FMY N/A
- EDAP $67,840,467.00
- Revenue This Year
- FMY N/A
- EDAP N/A
- Revenue Next Year
- FMY N/A
- EDAP N/A
- P/E Ratio
- FMY N/A
- EDAP N/A
- Revenue Growth
- FMY N/A
- EDAP 3.69
- 52 Week Low
- FMY $10.71
- EDAP $1.26
- 52 Week High
- FMY $12.17
- EDAP $5.46
- Technical
- Relative Strength Index (RSI)
- FMY 49.70
- EDAP 43.59
- Support Level
- FMY $12.00
- EDAP $1.75
- Resistance Level
- FMY $12.04
- EDAP $1.90
- Average True Range (ATR)
- FMY 0.09
- EDAP 0.12
- MACD
- FMY 0.00
- EDAP -0.01
- Stochastic Oscillator
- FMY 54.29
- EDAP 37.50
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.